Thienopyrimidines useful as Aurora kinase inhibitors
    3.
    发明申请
    Thienopyrimidines useful as Aurora kinase inhibitors 失效
    噻吩并嘧啶可用作极光激酶抑制剂

    公开(公告)号:US20060035908A1

    公开(公告)日:2006-02-16

    申请号:US11182215

    申请日:2005-07-15

    IPC分类号: A61K31/519 C07D498/02

    CPC分类号: C07D495/04

    摘要: The present invention provides compounds having the formula: wherein R1, R2, X1, X2, L1, L2, Y and Z are as defined in classes and subclasess herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases.

    摘要翻译: 本发明提供具有下式的化合物:其中R 1,R 2,X 1,X 2, L 1,L 2,Y和Z如本文中的类别和亚临界所定义,以及其在本文中通常和在本文中描述的药物组合物,该化合物可用作 蛋白激酶抑制剂(例如Aurora),因此可用于治疗Aurora介导的疾病。

    Compounds and methods for synthesis and therapy
    5.
    发明授权
    Compounds and methods for synthesis and therapy 有权
    用于合成和治疗的化合物和方法

    公开(公告)号:US06225341B1

    公开(公告)日:2001-05-01

    申请号:US09288091

    申请日:1999-04-08

    IPC分类号: A61K3135

    CPC分类号: C07D309/28 Y02P20/55

    摘要: Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.

    摘要翻译: 描述了新的化合物。 化合物通常包含酸性基团,碱性基团,取代的氨基或N-酰基和具有任选羟基化的烷烃部分的基团。 还描述了包含本发明抑制剂的药物组合物。 还描述了怀疑含有神经氨酸酶的样品中抑制神经氨酸酶的方法。 还描述了抗原物质,聚合物,抗体,本发明化合物与标记物的缀合物,以及用于检测神经氨酸酶活性的测定方法。